Xiyang Yang
Chongqing, 400010, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to "Tubeimoside I promotes angiogenesis via activation of eNOS-VEGF signaling pathway" [J. Ethonopharmacol. 267 (2021) 113642].
Journal: Journal of ethnopharmacology
Published: December 25, 2024
Tubeimoside I Ameliorates Myocardial Ischemia-Reperfusion Injury through SIRT3-Dependent Regulation of Oxidative Stress and Apoptosis.
Journal: Oxidative medicine and cellular longevity
Published: March 03, 2021
Hypertonic stress modulates eNOS function through O-GlcNAc modification at Thr-866.
Journal: Scientific reports
Published: February 17, 2021
Tubeimoside I protects against sepsis-induced cardiac dysfunction via SIRT3.
Journal: European journal of pharmacology
Published: January 06, 2021
Protective Effect of Sirtuin 3 on CLP-Induced Endothelial Dysfunction of Early Sepsis by Inhibiting NF-κB and NLRP3 Signaling Pathways.
Journal: Inflammation
Published: December 09, 2020
Tubeimoside I improves endothelial function in sepsis via activation of SIRT3.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: November 20, 2020
Tubeimoside I promotes angiogenesis via activation of eNOS-VEGF signaling pathway.
Journal: Journal of ethnopharmacology
Published: October 12, 2020
Tubeimoside I improves survival of mice in sepsis by inhibiting inducible nitric oxide synthase expression.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 24, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026